CARBAMAZEPINE | N018927 | NOVARTIS PHARMACEUTICALS CORP
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizens Petition from Taro Pharmaceuticals USA, Inc. FDA-2003-P-0352 Taro Pharmaceuticals USA, Inc. filed this citizen petition on July 1, 2003, requesting that the FDA determine ANDA suitability for Carbamazepine Oral Suspension USP, 200 mg/5 mL using Tegretol Oral Suspension, 100 mg/5 mL manufactured by Novartis Pharmaceuticals Corporation as the reference-listed d | Other | 2010-10-04 | Denied | Taro Pharmaceuticals USA |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.